A Scoping Review of Dehydrozingerone in Preclinical Pharmacology: Activities, Dose Ranges and Toxicity.

Mercado MC, Azmi N, Mohd Said M, Jalil J, Jamal JA, Yaakob NS.

Open source

DOI
10.1111/bcpt.70262
Published
2026-08-01
Container
Basic Clin Pharmacol Toxicol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcpt.70262,
  title = {A Scoping Review of Dehydrozingerone in Preclinical Pharmacology: Activities, Dose Ranges and Toxicity.},
  author = {Mercado MC and  Azmi N and  Mohd Said M and  Jalil J and  Jamal JA and  Yaakob NS.},
  year = {2026},
  journal = {Basic Clin Pharmacol Toxicol},
  doi = {10.1111/bcpt.70262},
  url = {https://doi.org/10.1111/bcpt.70262}
}

RIS

TY  - JOUR
TI  - A Scoping Review of Dehydrozingerone in Preclinical Pharmacology: Activities, Dose Ranges and Toxicity.
AU  - Mercado MC
AU  -  Azmi N
AU  -  Mohd Said M
AU  -  Jalil J
AU  -  Jamal JA
AU  -  Yaakob NS.
PY  - 2026
JO  - Basic Clin Pharmacol Toxicol
DO  - 10.1111/bcpt.70262
UR  - https://doi.org/10.1111/bcpt.70262
ER  - 

APA

MC, M., N, A., M, M. S., J, J., JA, J., & NS., Y. (2026). A Scoping Review of Dehydrozingerone in Preclinical Pharmacology: Activities, Dose Ranges and Toxicity.. Basic Clin Pharmacol Toxicol. https://doi.org/10.1111/bcpt.70262

Source records